Fundz

Fundz Deep Dive

Everything you need to win Huons — in one platform.

Who to reach, what to say, and why now on Huons — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Huons — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Huons Biopharma partners with VERNI Aesthetics for fat-decomposition injection MRC101

Nov 29, 2024•over 1 year ago

Contract Type

partnership

Seongnam-siManufacturingBiotechnologyBiopharma

Description

Huons Biopharma has announced a partnership with VERNI Aesthetics to jointly advance the development of fat-decomposition injection MRC101, which aims to revolutionize cosmetic treatments and enhance patient outcomes.

Company Information

Company

Huons

Location

Seongnam-si, Gyeonggi, South Korea

About

Huons is a leading healthcare company specializing in pharmaceuticals and medical devices. The company focuses on providing innovative health solutions for various medical needs. Huons is recognized for its commitment to improving patient care. The company's operations extend across multiple countries.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Huons's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.